$0.30 -0.00 (-0.03%)
BioVie Inc. Warrant (BIVIW)
Company News
BioVie to Host Live Investor Webinar and Q&A on Oct. 8
BioVie Inc. will host an investor webinar discussing its drug therapies for neurological diseases, focusing on bezisterim for Alzheimer's, Parkinson's, and long COVID, and BIV201 for liver cirrhosis complications.